Trials / Completed
CompletedNCT00876031
Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma
A Randomised Phase-III Trial of the Cooperative Weichteilsarkom Study Group (CWS) for Localised High-risk Rhabdomyosarcoma and Localised Rhabdomyosarcoma-like Soft Tissue Sarcoma in Children, Adolescents, and Young Adults
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 195 (actual)
- Sponsor
- University Hospital Tuebingen · Academic / Other
- Sex
- All
- Age
- 6 Months – 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate whether the addition of oral maintenance chemotherapy with O-TIE (Etoposide, Idarubicin, Trofosfamide) for 6 months improves the event free survival (EFS) in patients with localised high-risk RMS and RMS-like Soft Tissue Sarcoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | trofosfamide, idarubicin, etoposide | oral maintenance therapy for 6 months |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2022-06-30
- Completion
- 2022-06-30
- First posted
- 2009-04-06
- Last updated
- 2022-11-08
Locations
87 sites across 5 countries: Austria, Germany, Poland, Sweden, Switzerland
Source: ClinicalTrials.gov record NCT00876031. Inclusion in this directory is not an endorsement.